ST-segment elevation myocardial infarction is a major cause of morbidity and mortality
worldwide. Reperfusion injury (RI) following the opening of an occluded coronary artery …

Prompt reperfusion therapy in acute myocardial infarction enhances clinical outcome.
However, reperfusion itself may contribute to myocardial cell death. The current review …

Acute myocardial infarction (AMI) is a major cause of morbidity and mortality worldwide.
Timely reperfusion with primary percutaneous coronary intervention (PPCI) remains the gold …

Cardiomyocyte death secondary to transient ischemia occurs mainly during the first minutes
of reperfusion, in the form of contraction band necrosis involving sarcolemmal rupture …

Even when reperfusion therapy is applied as early as possible, survival and quality of life
are compromised in a considerable number of patients with ST-segment elevation acute …

The principal therapy in patients with myocardial infarction to limit infarct size is myocardial
reperfusion by mechanical or pharmacological intervention. Reperfusion has been …

Coronary heart disease (CHD) is the leading cause of death and disability in Europe. For
patients presenting with an acute ST-segment elevation myocardial infarction (STEMI) …

Effective primary and secondary prevention and advances in cardiac surgery have
significantly improved the care and outcomes of patients with myocardial ischemia. While …

Reperfusion by means of percutaneous coronary intervention or thrombolytic therapy is the
most effective treatment for acute myocardial infarction, markedly reducing mortality and …

Ischaemic heart disease (IHD) remains the leading cause of death and disability in Europe
and worldwide. A major cause of morbidity and mortality in IHD patients is an acute ST …